{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:28:40Z","timestamp":1793046520528,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":629,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jtct.2021.05.020","type":"journal-article","created":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T02:20:54Z","timestamp":1622427654000},"page":"780.e1-780.e14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Donor-Host Lineage-Specific Chimerism Monitoring and Analysis in Pediatric Patients Following Allogeneic Stem Cell Transplantation: Influence of Pretransplantation Variables and Correlation with Post-Transplantation Outcomes"],"prefix":"10.1016","volume":"27","author":[{"given":"Gabriela","family":"Llaurador","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"Nicoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Prockop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Mauguen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"O'Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap J.","family":"Boelens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farid","family":"Boulad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2021.05.020_bib0001","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1200\/JCO.1983.1.9.517","article-title":"Karnofsky Memorial Lecture. Marrow transplantation for malignant diseases","volume":"1","author":"Thomas","year":"1983","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2021.05.020_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bmt.1704525","article-title":"Significance of chimerism in hematopoietic stem cell transplantation: new variations on an old theme","volume":"34","author":"Khan","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.05.020_bib0003","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.bbmt.2014.10.010","article-title":"Outcomes of donor lymphocyte infusion for treatment of mixed donor chimerism after a reduced-intensity preparative regimen for pediatric patients with nonmalignant diseases","volume":"21","author":"Haines","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.05.020_bib0004","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/pbc.24259","article-title":"Outcomes of immunological interventions for mixed chimerism following allogeneic stem cell transplantation in children with juvenile myelomonocytic leukemia","volume":"60","author":"Inagaki","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2021.05.020_bib0005","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/bmt.2017.45","article-title":"Safety of pre-emptive donor lymphocyte infusions (DLI) based on mixed chimerism (MC) in peripheral blood or bone marrow subsets in children undergoing hematopoietic stem cell transplant (HSCT) for hematologic malignancies","volume":"52","author":"Liou","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.05.020_bib0006","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/sj.bmt.1705576","article-title":"Assessing quantitative chimerism longitudinally: technical considerations, clinical applications and routine feasibility","volume":"39","author":"Kristt","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.05.020_bib0007","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.bbmt.2019.11.010","article-title":"Relapse of aplastic anemia with majority donor chimerism (donor-type aplasia) occurring late after bone marrow transplantation","volume":"26","author":"Shaw","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.05.020_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154737","article-title":"Long-term stable mixed chimerism after hematopoietic stem cell transplantation in patients with non-malignant disease, shall we be tolerant?","volume":"11","author":"Stikvoort","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jtct.2021.05.020_bib0009","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/978-1-4614-9437-9_14","article-title":"Post-transplant monitoring of chimerism by lineage-specific analysis","volume":"1109","author":"Preuner","year":"2014","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jtct.2021.05.020_bib0010","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3324\/haematol.2015.135137","article-title":"Risk assessment of relapse by lineage-specific monitoring of chimerism in children undergoing allogeneic stem cell transplantation for acute lymphoblastic leukemia","volume":"101","author":"Preuner","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2021.05.020_bib0011","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/petr.12580","article-title":"Chimerism analysis in clinical practice and its relevance for the detection of graft rejection and malignant relapse in pediatric hematopoietic stem cell transplant patients","volume":"19","author":"Mellgren","year":"2015","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jtct.2021.05.020_bib0012","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/bjh.14008","article-title":"Peripheral blood late mixed chimerism in leucocyte subpopulations following allogeneic stem cell transplantation for childhood malignancies: does it matter?","volume":"173","author":"Pichler","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2021.05.020_bib0013","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.bbmt.2011.02.002","volume":"17","author":"Devine","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.05.020_bib0014","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1182\/blood-2007-06-093880","article-title":"T cell-depleted stem cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin","volume":"110","author":"Jakubowski","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.05.020_bib0015","first-page":"563","article-title":"Depletion of T cells from bone marrow grafts with soybean agglutinin and sheep red blood cells for prevention of graft-versus-host disease","volume":"30","author":"Verdonck","year":"1987","journal-title":"Haematol Blood Transfus"},{"key":"10.1016\/j.jtct.2021.05.020_bib0016","first-page":"427","article-title":"New technology for the depletion of T cells from soybean lectin agglutinated, HLA-matched bone marrow grafts for leukemia: initial laboratory and clinical results","volume":"377","author":"Collins","year":"1992","journal-title":"Prog Clin Biol Res"},{"key":"10.1016\/j.jtct.2021.05.020_bib0017","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1053\/bbmt.2001.v7.pm11669214","volume":"7","author":"Antin","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.05.020_bib0018","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/bjh.13073","volume":"168","author":"Clark","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2021.05.020_bib0019","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1046\/j.1365-2141.1997.1112925.x","article-title":"IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade","volume":"97","author":"Rowlings","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2021.05.020_bib0020","first-page":"250","article-title":"Chronic graft-versus-host disease and other late complications of bone marrow transplantation","volume":"28","author":"Sullivan","year":"1991","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jtct.2021.05.020_bib0021","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/sj.leu.2402017","article-title":"Analysis of chimerism within specific leukocyte subsets for detection of residual or recurrent leukemia in pediatric patients after allogeneic stem cell transplantation","volume":"15","author":"Lion","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2021.05.020_bib0022","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1038\/leu.2012.66","article-title":"The EuroChimerism concept for a standardized approach to chimerism analysis after allogeneic stem cell transplantation","volume":"26","author":"Lion","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2021.05.020_bib0023","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.2165\/00003088-200645110-00003","article-title":"Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations","volume":"45","author":"Bartelink","year":"2006","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jtct.2021.05.020_bib0024","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJMra035092","article-title":"Developmental pharmacology\u2013drug disposition, action, and therapy in infants and children","volume":"349","author":"Kearns","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2021.05.020_bib0025","article-title":"Hematopoietic cell transplantation for treatment of primary immune deficiencies","volume":"2","author":"Burroughs","year":"2010","journal-title":"Cell Ther Transplant"},{"key":"10.1016\/j.jtct.2021.05.020_bib0026","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/bmt.2015.277","article-title":"Long-term outcomes of fludarabine, melphalan and antithymocyte globulin as reduced-intensity conditioning regimen for allogeneic hematopoietic stem cell transplantation in children with primary immunodeficiency disorders: a prospective single center study","volume":"51","author":"Hamidieh","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.05.020_bib0027","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1182\/blood-2017-03-772392","article-title":"At least 20% donor myeloid chimerism is necessary to reverse the sickle phenotype after allogeneic HSCT","volume":"130","author":"Fitzhugh","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.05.020_bib0028","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/sj.bmt.1702151","article-title":"Long-term survival of ex-thalassemic patients with persistent mixed chimerism after bone marrow transplantation","volume":"25","author":"Andreani","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.05.020_bib0029","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.blre.2007.10.001","article-title":"Advances in the allogeneic transplantation for thalassemia","volume":"22","author":"Lucarelli","year":"2008","journal-title":"Blood Rev"},{"key":"10.1016\/j.jtct.2021.05.020_bib0030","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1182\/blood-2014-02-514778","article-title":"Conditioning regimens for hematopoietic cell transplantation: one size does not fit all","volume":"124","author":"Gyurkocza","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.05.020_bib0031","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1074-7613(01)00122-4","article-title":"Mixed chimerism and transplant tolerance","volume":"14","author":"Sykes","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.jtct.2021.05.020_bib0032","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1586\/eci.12.9","article-title":"Reduced-intensity conditioning for allogeneic stem cell transplant in primary immune deficiencies","volume":"8","author":"Chiesa","year":"2012","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jtct.2021.05.020_bib0033","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/sj.bmt.1705923","article-title":"Reduced-intensity conditioning and allogeneic stem cell transplantation in childhood malignant and nonmalignant diseases","volume":"41","author":"Satwani","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.05.020_bib0034","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1182\/blood.V97.10.2962","article-title":"Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia","volume":"97","author":"Rocha","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.05.020_bib0035","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/S0140-6736(07)60915-5","article-title":"Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study","volume":"369","author":"Eapen","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jtct.2021.05.020_bib0036","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1002\/cncr.30792","article-title":"Multisite external validation of a risk prediction model for the diagnosis of blood stream infections in febrile pediatric oncology patients without severe neutropenia","volume":"123","author":"Esbenshade","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.jtct.2021.05.020_bib0037","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.bbmt.2017.06.013","article-title":"Durable chimerism and long-term survival after unrelated umbilical cord blood transplantation for pediatric hemophagocytic lymphohistiocytosis: a single-center experience","volume":"23","author":"Patel","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.05.020_bib0038","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1182\/blood-2008-03-140830","article-title":"Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes","volume":"112","author":"Prasad","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.05.020_bib0039","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/bjh.12918","article-title":"Peripheral blood cells chimerism after unrelated cord blood transplantation in children: kinetics, predictive factors and impact on post-transplant outcome","volume":"166","author":"Elkaim","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2021.05.020_bib0040","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1517\/14656566.2014.852537","article-title":"Current and future approaches to treat graft failure after allogeneic hematopoietic stem cell transplantation","volume":"15","author":"Locatelli","year":"2014","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jtct.2021.05.020_bib0041","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1365-2141.2008.07533.x","volume":"144","author":"Lawler","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2021.05.020_bib0042","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.bbmt.2019.10.004","article-title":"Mixed chimerism and secondary graft failure in allogeneic hematopoietic stem cell transplantation for aplastic anemia","volume":"26","author":"Kako","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.05.020_bib0043","first-page":"588","article-title":"Chimerism analysis in long-term survivor patients after bone marrow transplantation for severe aplastic anemia","volume":"82","author":"Gomez","year":"1997","journal-title":"Haematologica"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636721009398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636721009398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:01:36Z","timestamp":1763002896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636721009398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S2666636721009398"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2021.05.020","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Donor-Host Lineage-Specific Chimerism Monitoring and Analysis in Pediatric Patients Following Allogeneic Stem Cell Transplantation: Influence of Pretransplantation Variables and Correlation with Post-Transplantation Outcomes","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2021.05.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}